2m 2m 2m 2m 2m 2m 2m
TG Therap (TGTX)
NASDAQ
$55.25+$0.98 (+1.80%)
Price as of Aug 21, 2026 7:57 PM EDT- $8.3BMarket Cap
- 84.31%1-Year Change
- BiotechnologyIndustry
TG Therap (TGTX)
$55.25+$0.98 (+1.80%)
TGTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $54.27 | ||
Change | +$3.71 (+7.34%) | ||
Open | $51.10 | ||
High | $56.87 | ||
Low | $49.97 | ||
Previous Close | $50.56 | ||
Volume | 5,558,340 | ||
30-Day Average Volume | 2,352,518 | ||
1-Week Change | 11.35% | ||
1-Month Change | 0.59% | ||
1-Year Change | 84.31% | ||
3-Year Change | 423.34% | ||
5-Year Change | 126.13% | ||
Fundamentals | |||
Shares Outstanding | 153.1M | ||
Total Assets | $1.6B | ||
Market Cap | $8.3B | ||
Enterprise Value | $8.6B | ||
Period: QTR TTM FY | |||
Revenue | $235.8M | ||
Net Income | $7.8M | ||
Free Cash Flow | $39.0M | ||
EBIT | $10.2M | ||
EBITDA | $10.3M | ||
Net Working Capital | $877.2M | ||
EPS | $0.05 | ||
Enterprise Value/EBITDA | 833 | ||
Enterprise Value/Revenue | 36 | ||
P/B | 14 | ||
P/E | 1,085 | ||
PEG | -19 | ||
Price/Free Cash Flow | 213 | ||
Price/Operating Cash Flow | 212 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 56.25 | ||
Last Split Date | 04/30/2012 | ||
Earnings & Revenue